TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer.

Rahul R Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.